Cardiometabolic risk factors exponentially raise CVD incidence and mortality rates: a call for comprehensive management

Patients who had a hysterectomy at age 30 or younger had higher rates of regret compared with those who had the procedure after 30, a

Participants in a phase I trial lost a placebo-adjusted 6.1% of their body weight after 4 weeks of treatment with the investigational oral GLP-1 receptor

John­son & John­son scored an FDA ap­proval for Op­syn­vi, a com­bo of the en­dothe­lin re­cep­tor an­tag­o­nist Op­sum­it and the phos­pho­di­esterase 5 in­hibitor tadalafil, for the